No retraction, correction or concern found when last checked on Oct 25, 2026.
Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice
Clare M Smith, Richard E Baker, Megan K Proulx and 23 more
eLife · 2022 · CC BY
Abstract
The outcome of an encounter with Mycobacterium tuberculosis ( Mtb ) depends on the pathogen’s ability to adapt to the variable immune pressures exerted by the host. Understanding this interplay has proven difficult, largely because experimentally tractable animal models do not recapitulate the heterogeneity of tuberculosis disease. We leveraged the genetically diverse Collaborative Cross (CC) mouse panel in conjunction with a library of Mtb mutants to create a resource for associating bacterial genetic requirements with host genetics and immunity. We report that CC strains vary dramatically in their susceptibility to infection and produce qualitatively distinct immune states. Global analysis of Mtb transposon mutant fitness (TnSeq) across the CC panel revealed that many virulence pathways are only required in specific host microenvironments, identifying a large fraction of the pathogen’s genome that has been maintained to ensure fitness in a diverse population. Both immunological and bacterial traits can be associated with genetic variants distributed across the mouse genome, making the CC a unique population for identifying specific host-pathogen genetic interactions that influence pathogenesis.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 25, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Infection with Mycobacterium tuberculosis (Mtb) produces heterogeneous outcomes that are influenced by genetic and phenotypic variation in both the host and the pathogen. Classic human genetic studies show that host variation influences immunity to tuberculosis (TB). Likewise, the co-evolution of Mtb with different populations across the globe has produced genetically distinct lineages that demonstrate variable virulence traits. The role of genetic variation on each side of this interaction is established, yet the intimate evolutionary history of both genomes suggests that interactions between host and pathogen variants may represent an additional determinant of outcome. Evidence for genetic interactions between host and pathogen genomes have been identified in several infections, including TB. However, the combinatorial complexity involved in identifying these relationships in natural populations have left the mechanisms largely unclear.
Mouse models have proven to be a powerful tool to understand mechanisms of susceptibility to TB. Host requirements for protective immunity were discovered by engineering mutations in the genome of standard laboratory strains of mice, such as C57BL/6 (B6), revealing a critical role of Th1 immunity. Mice lacking factors necessary for the production of Th1 cells or the protective cytokine interferon gamma (IFNγ) are profoundly susceptible to Mtb infection. Defects in this same immune axis cause the human syndrome Mendelian Susceptibility to Mycobacterial Disease (MSMD), demonstrating the value of knockout (KO) mice to characterize genetic variants of large effect. Similarly, the standard mouse model has been used to define Mtb genes that are specifically required for optimal bacterial fitness during infection.
Despite the utility of standard mouse models, it has become increasingly clear that the immune response to Mtb in genetically diverse populations is more heterogeneous than any single small animal model. For example, while IFNγ-producing T cells are critical for protective immunity in standard inbred lines of mice, a significant fraction of humans exposed to Mtb control the infection without producing a durable IFNγ response. Similarly, IL-17 producing T cells have been implicated in both protective responses and inflammatory tissue damage in TB, but IL-17 has little effect on disease progression in B6 mice, except in the context of vaccination or infection with particularly virulent Mtb. The immunological homogeneity of standard mouse models may also explain why only a small minority of the >4000 genes that have been retained in the genome of Mtb during its natural history promote fitness in the mouse. Thus, homogenous mouse models of TB fail to capture the distinct disease states, mechanisms of protective immunity, and selective pressures on the bacterium that are observed in natural populations.
The Collaborative Cross (CC) and Diversity Outbred (DO) mouse populations are new mammalian resources that more accurately represent the genetic and phenotypic heterogeneity observed in outbred populations. These mouse panels are both derived from the same eight diverse founder strains but have distinct population structures. DO mice are maintained as an outbred population and each animal represents a unique and largely heterozygous genome. In contrast, each inbred CC strain’s genome is almost entirely homozygous, producing a genetically stable and reproducible population in which the phenotypic effect of recessive mutations is maximized. Together, these resources have been leveraged to identify host loci underlying the immune response to infectious diseases. In the context of TB, DO mice have been used as individual, unique hosts to identify correlates of disease, which resemble those observed in non-human primates and humans. Small panels of the reproducible CC strains have been leveraged to identify host background as a determinant of the protective efficacy of BCG vaccination and a specific variant underlying protective immunity to tuberculosis. While these studies demonstrate the tractability of the DO and CC populations to model the influence of host diversity on infection, dissecting host-pathogen interactions requires the integration of pathogen genetic diversity.
We combined the natural but reproducible host variation of the CC panel with a comprehensive library of Mtb transposon mutants to determine whether the CC population could be used to characterize the interactions between host and pathogen. Using over 60 diverse mouse strains, we report that the CC panel encompasses a broad spectrum of TB susceptibility and immune phenotypes. By leveraging high-resolution bacterial phenotyping known as ‘Transposon Sequencing’ (TnSeq), we quantified the relative fitness of a saturated library of Mtb mutants across the CC panel and specific immunological mouse knockout strains. We report that approximately three times more bacterial genes contribute to fitness in the diverse panel than in any single mouse strain, defining a large fraction of the bacterial genome that is dedicated to adapting to distinct immune states. Association of both host immunological phenotypes and bacterial fitness traits with Quantitative Trait Loci (QTL) demonstrated the presence of discrete Host-Interacting-with Pathogen QTL (HipQTL) that represent inter-species genetic interactions that influence the pathogenesis of this infection. Together, these observations support the CC population as a tractable model of host diversity that greatly expands the spectrum of immunological and pathological states that can be modeled in the mouse.
The spectrum of TB disease traits in the CC exceeds that observed in standard inbred mice
To characterize the diversity of disease states that are possible in a genetically diverse mouse population, we infected a panel of 52 CC lines and the eight founder strains with Mtb. To enable bacterial transposon sequencing (TnSeq) studies downstream, the animals were infected via the intravenous (IV) route with a saturated library of Mtb transposon mutants (infectious dose of 105 CFU), which in sum produce an infection that is similar to the wild-type parental strain. Groups of three to six male mice per genotype were infected and TB disease-related traits were quantified at one-month post-infection. Data from all surviving animals that were phenotyped are provided in Figure 1—source data 1. The bacterial burden after 4 weeks of infection was assessed by plating (colony-forming units, CFU) and quantifying the number of bacterial chromosomes in the tissue (chromosome equivalents, CEQ). These two metrics were highly correlated (r = 0.88) and revealed a wide variation in bacterial burden across the panel (Figure 1A and Figure 1—figure supplement 1). The phenotypes of the inbred founder strains were largely consistent with previous studies employing an aerosol infection, where the WSB strain was more susceptible than the more standard B6, 129S1/SvlmJ (129), and NOD/ShiLtJ (NOD) strains. Across the entire CC panel, lung bacterial burden varied by more than 1000-fold, ranging from animals that are significantly more resistant than B6, to mice that harbored more than 109 bacteria in their lungs (Figure 1A). Bacterial burden in the spleen also varied several thousand-fold across the panel and was moderately correlated with lung burden (r = 0.43) (Figure 1—figure supplement 1). Thus, the CC panel encompasses a large quantitative range of susceptibility.
Comparing various measures of infection progression showed many expected correlations but also an unexpected decoupling of some phenotypes. As an initial assessment of the disease processes in these animals, we correlated bacterial burden and lung cytokine abundance with measures of systemic disease such as weight loss and sufficient morbidity to require euthanasia (‘earliness of death’). In general, correlations between these metrics indicated that systemic disease was associated with bacterial replication and inflammation (Figure 1B and Figure 1—figure supplement 1). Lung CFU was strongly correlated with weight loss, mediators that enhance neutrophil differentiation or migration (CXCL2 (MIP-2; r = 0.79), CCL3 (MIP-1a; r = 0.77), G-CSF (r = 0.78), and CXCL1 (KC; r = 0.76)), and more general proinflammatory cytokines (IL-6 (r = 0.80) and IL-1α (r = 0.76)) (Figure 1—figure supplement 1). These findings are consistent with previous work in the DO panel, that found both proinflammatory chemokines and neutrophil accumulation to be predictors of disease.
The reproducibility of CC genotypes allowed us to quantitatively assess the heritability (h2) of these immunological and disease traits. The percent of the variation attributed to genotype ranged from 56%–87% (mean = 73.4%; (Appendix 1—table 1)). The dominant role of genetic background in determining the observed phenotypic range allowed a more rigorous assessment of strains possessing outlier phenotypes than is possible in the DO population, based on linear regression using studentized residuals that accounts for the intragenotype variation. For example, despite the correlation between lung CFU and weight loss (r = 0.57), several strains failed to conform to this relationship (Figure 1C). In particular, CC030/GeniUnc (p = 0.003), CC040/TauUnc (p = 0.027) and A/J (p = 0.03) lost more weight than their bacterial burdens would predict (Figure 1C; noted by #). Similarly, CXCL1 abundance was higher in CC030/GeniUnc (p = 0.001) and lower in CC056/GeniUnc (p = 0.040), than the level predicted by their respective bacterial burden (Figure 1C; outlier genotypes noted by †). Thus, these related disease traits can be dissociated based on the genetic composition of the host.
The cluster of cytokines that was most notably unrelated to bacterial burden included IFNγ and the interferon-inducible chemokines CXCL10 (IP10), CXCL9 (MIG), and CCL5 (RANTES) (Red cluster in Figure 1B; Figure 1—figure supplement 1) (R < 0.3). Despite the clear protective role for IFNγ, high levels have been observed in susceptible mice, likely as a result of high antigen load. While high IFNγ levels in susceptible animals was therefore expected, it was more surprising to find a number of genotypes that were able to control bacterial replication yet had very low levels of this critically important cytokine (Figure 1D). This observation is likely due the inclusion of two founder lines, CAST/EiJ (CAST) and PWK/PhJ (PWK) that we previously found to display this unusual phenotype.
To assess the reproducibility of these findings in an aerosol infection model, we tested four CC genotypes that were susceptible by IV infection, including CC027, CC032, CC037, and CC042. We infected groups of 4–6 mice per genotype with H37Rv strain via low-dose aerosol infection (~100 CFU), including B6 mice as resistant controls. At 4-weeks post infection, we quantified lung CFU, lung cytokine abundance and weight loss as measurements of TB disease. Compared to the resistant B6 mice, the selected CC strains demonstrated higher bacterial burden in the lung (Figure 1E) and significant weight loss (Figure 1F), thus validating disease traits as consistent across both route and dose. Likewise, cytokines that were highly correlated with lung burden in the CC screen (Figure 1B, Figure 1—figure supplement 1) were consistent in the aerosol validation study (Figure 1—figure supplement 2). Notably, CXCL1 was consistently high in the susceptible genotypes, as compared to B6 (Figure 1G), and was highly correlated with lung burden by both IV (R = 0.76) and aerosol (R = 0.92) routes. IFNγ levels were variable across the strains (Figure 1H) and did not correlate with lung CFU (R = −0.22), concordant with findings from the CC screen (R = −0.21). Altogether, this survey of TB-related traits demonstrated a broad range of susceptibility and the presence of qualitatively distinct and genetically determined disease states.
TipQTL define genetic variants that control TB immunophenotypes
Tuberculosis ImmunoPhenotype Quantitative Trait Loci (TipQTL), which were associated with TB disease or cytokine traits, were identified and numbered in accordance with previously reported TipQTL. Of the 32 TB-disease traits, we identified nine individual metrics that were associated with a chromosomal locus. Of these, three were associated with high confidence (p ≤ 0.053), and six other QTL met a suggestive threshold as determined by permutation analysis (p < 0.2; Table 1). Several individual trait QTL occupied the same chromosomal locations. For example, spleen CFU and spleen CEQ, which are both measures of bacterial burden and highly correlated, were associated with the same interval on distal chromosome 2 (Table 1, Tip5; Figure 2A and C). IL-10 abundance was associated with two distinct QTL (Table 1). While IL-10 was only moderately correlated with spleen CFU (R = 0.48), one of its QTL fell within the Tip5 bacterial burden interval on chromosome 2 (Figure 2A and C). At this QTL, the NOD haplotype was associated with high values for all three traits (Figure 2E). Similarly, the strongly correlated traits, CXCL1 abundance and lung CFU, were individually associated to the same region on chromosome 7 (Table 1, Tip8; Figure 2B and D). In this interval, the CAST haplotype was associated with both low bacterial burden and CXCL1 (Figure 2F). At both Tip5 and Tip8, we found no statistical evidence that the positions of the associated QTL were different (Tip5 p = 0.55; Tip8 p = 0.27; 400 bootstrap samples). These observations support the role of a single causal variant at each locus that is responsible for a pleiotropic trait. Coincident mapping can provide both additional statistical support for QTL (p values by Fisher’s combined probability test: Chr 7, p = 0.067; Chr 2, p = 0.041) and suggests potential mechanisms of disease progression.
A number of factors can limit the statistical significance of QTL identified in the CC population, including small effect sizes, limited genotype availability, and the genetic complexity of the trait. We took an F2 intercross approach to independently assess the importance of the lung CFU QTL on chromosomes 7 and 15 (Tip8 and Tip10, Table 1). Given that the associations at both QTL were driven by the CAST haplotype (Figure 2F), we generated an F2 population based on two CC strains, CC029/Unc and CC030/GeniUnc, that contained CAST sequence at Tip8 and Tip10, respectively (Figure 3A and B). The F2 validation cohort (n = 251 mice) were genotyped and infected with the Mtb strain H37Rv (IV route with infectious dose of 105 CFU, as per the original CC screen). At 1 month post infection, lung CFU was quantified, and we conducted QTL mapping in R/qtl2 to identify host loci underlying bacterial burden in the lung. We identified a QTL significantly associated with lung CFU (LOD = 6.81; p < 0.05; 10,000 permutations) on chromosome seven that overlapped with Tip8 (peak position Chr7:28.6 Mb), thus validating this locus as a main driver of bacterial burden. In this reduced complexity cross, we did not observe a QTL on chromosome 15 (Tip10). This may be due to the B6 haplotype at this locus in CC030, which did not represent the strongest phenotypic contrast to CAST. Additionally in the mapping validation study, we identified a new resistance (low lung CFU) locus on chromosome 8 (LOD = 4.08; peak position Ch8:116.1 Mb), driven by the CC029 cross partner with the CAST haplotype. This QTL was not present in the original CC screen, probably due to the low representation of the CAST haplotype at that marker in the CC cohort tested. Altogether, this intercross strategy validated Tip8 as a strong predictor of lung CFU, though rigorous validation of Tip10 may require a more optimal pairing of parental strains.
Mtb adapts to diverse hosts by utilizing distinct gene repertoires
This survey of disease-associated traits demonstrated that the CC panel encompasses a number of qualitatively distinct immune phenotypes. To determine if different bacterial functions were necessary to adapt to these conditions, we leveraged transposon sequencing (TnSeq) as a high-resolution phenotyping approach to estimate the relative abundance of individual Mtb mutants after selection in each CC host genotype. To serve as benchmarks of known immunological lesions, we also performed TnSeq in B6 mice that were lacking the mediators of Th1 immunity, lymphocytes (Rag2-/-) and IFNγ (Ifng-/-), or were lacking the immunoregulatory mediators that control disease by inhibiting inflammation, nitric oxide synthase (Nos2-/-) or the NADPH phagocyte oxidase (Cybb-/-). The relative representation of each Mtb mutant in the input library versus the output library recovered from each mouse spleen after one-month of infection was quantified by TnSeq. A total of 123 saturated Mtb transposon libraries (representing >50,000 independent insertion events) were sequenced, capturing 60 distinct mouse genotypes (Figure 4—source data 1).
From this TnSeq screen, we identified 214 Mtb genes that are required for growth or survival of Mtb in B6 mice, based on significant underrepresentation of the corresponding mutant after four weeks of in vivo selection. Eighty-seven percent of these genes overlapped with a similar previous analysis in BALB/c mice highlighting the specificity of the analysis. All but one of the genes found to be important in B6, were also required in the larger mouse panel, further increasing confidence in this Mtb gene set (Figure 4A and B). While the total number of genes found to be necessary in each genotype across the diversity panel was largely similar, the composition of these Mtb gene sets varied considerably. As more CC strains, and presumably more distinct immune states, were included in the analysis, the cumulative number of bacterial genes necessary for growth in these animals also increased. This cumulative gene set plateaued at ~750, after the inclusion of approximately 20–25 mouse genotypes (Figure 4A). Simply sampling additional libraries of B6 does not appreciably increase the number of genes identified as necessary for growth in that genotype (Figure 4—figure supplement 1), supporting the presence of alternative selective environments across the CC mice. The number of genes important for fitness in the CC panel far outnumbered the 380 genes identified in the B6 and immunodeficient KO strains combined (Figure 4B and Figure 4—source data 1).
To verify that our TnSeq study accurately assessed the effect of the corresponding loss-of-function alleles, we assessed the phenotypes of selected bacterial deletion mutants in a small set of mouse genotypes that were predicted to produce differential selection. Individual Mtb mutants lacking genes necessary for ESX-1 Type VII secretion (eccB1), siderophore-mediated iron acquisition (mbtA), phosphate transport (pstC2), glycerol catabolism (glpK), and RNA processing (rnaseJ) were generated and tagged with a unique molecular barcode. These mutants were combined with a barcoded wild-type parental strain, and the resulting ‘mini-pool’ was subjected to in vivo selection after IV infection of a sub-panel of mouse strains, as in the original screen. The relative abundance of each mutant was determined by sequencing the amplified barcodes and data from all reliably detected strains is shown in (Figure 4; Figure 4—source data 2). In each case, the difference in relative abundance predicted by TnSeq was reproduced with deletion mutants. In this simplified system, we were able to accurately quantify the expansion of the bacterial population and calculate the ‘fitness’ of each mutant relative to the wild-type strain. Fitness reflects the inferred doubling time of the mutant, where a fitness of 1 is defined as wild-type, and 0 represents a complete lack of growth. Even by this metric, the deletion mutants displayed the differences in fitness between mouse strains that was predicted by TnSeq (Figure 4C). The statistical significance of these differences in abundance or fitness were similar for each mutant (between p = 0.009 and p = 0.06), except for mbtA where the variation was higher, and confidence was modestly lower (p = 0.07 and p = 0.12). This study also allowed us to estimate the sensitivity of the TnSeq method, which could detect even the 30% fitness defect of the ∆glpK strain between the B6 and CC018 animals (Figure 4C), a defect that was not observed in previous studies in BALB/c mice.
To also validate TnSeq predictions in a single-strain aerosol infection model, we used a biotin biosynthetic mutant. bioA is necessary for biotin production and is essential for growth in B6 mice. Our TnSeq study (Figure 4—source data 1) predicted this mutant was less attenuated in the CAST background (ratio of input/selected = 12.1) than in the B6 strain (ratio of input/selected = 42.2). Two weeks after aerosol infection, we found that the ∆bioA mutant was cleared from the lungs and spleen of B6 mice but displayed similar growth to wild-type in the lungs of CAST mice (Figure 4D). By 6 weeks post-infection the ∆bioA mutant had also been largely cleared from the lungs of CAST (Figure 4D). Thus, while TnSeq was unable predict long-term outcome, it provided an accurate assessment of relative growth attenuation in these host backgrounds.
The immunological diversity of CC mice is reflected in the pathogen’s genetic requirements
The distribution of Mtb’s requirements across the mouse panel suggested the presence of two broad categories of genes. A set of 136 ‘core’ virulence functions were required in the majority of mouse genotypes, and a second larger set of 607 ‘adaptive’ virulence genes were required in only a subset of lines (Figure 4—source data 1). The core functions included a number of genes previously found to be important in B6 mice, including those necessary for the synthesis of essential cofactors, such as pyridoxine (pdx1); for the acquisition of nutrients, such as siderophore-bound iron (irtAB), cholesterol (mce4), glutamine (glnQ and rv2563) and for Type VII secretion (ESX1 genes). Despite the importance of these core functions, a large range in the relative abundance of these mutants was observed across the panel, and in some cases specific immunological requirements could be discerned. Mutants lacking the major structural components of the ESX1 system were attenuated for growth in B6 mice, as expected. This requirement was enhanced in mice lacking Rag2, Ifng, or Nos2 (Figure 4E), consistent with the preferential role of ESX1 during the initial stage of infection before the initiation of adaptive immunity, which is prolonged in these immunodeficient strains. In contrast, the attenuation of mutants lacking the glnQ encoded glutamine uptake system was relieved in all four immunodeficient mouse lines (Figure 4E). In both cases, the differential mutant abundance observed in these KO mice was reproduced, or exceeded, in the CC panel.
The adaptive virulence functions included a number of Mtb genes previously thought to be dispensable in the mouse model and were only necessary in CC strains. For example, the alkyl hydroperoxide reductase, AhpC has been proposed to function with the adjacently encoded peroxiredoxin, AhpD and is critical for detoxifying reactive nitrogen intermediates in vitro. However, deletion of ahpC has no effect on Mtb replication in B6 or BALB/c mice, and we confirmed that ahpC and ahpD mutations had no effect in any of the B6-derived strains. In contrast, ahpC, but not ahpD mutants were highly attenuated in a small number of CC strains (Figure 4E). Similarly, the four phospholipase C enzymes of Mtb (plcA-D) are implicated in both fatty acid uptake and modifying host cell membranes but are dispensable for replication in B6 mice. Again, while we found that none of these genes were required in B6-derived KO mouse strains, the plcD mutants were specifically underrepresented in a number of CC mice (Figure 4E). These individual bacterial functions are controlled by regulatory proteins, such as the extracytoplasmic sigma factors. Despite the importance of these transcription factors in the response to stress, only sigF has consistently been shown to contribute to bacterial replication in standard inbred lines of mice. Our study assessed the importance of each sigma factor in parallel across diverse host genotypes and identified a clear role for several of these regulators. sigC, sigI, sigF, sigL, and sigM mutants were each significantly underrepresented in multiple strains of mice, and several of these phenotypes were only apparent in the diverse CC animals (Figure 4E). In sum, the 607 adaptive functions that are differentially required across the host panel represents nearly 20% of the non-essential gene set of Mtb, suggesting that a significant fraction of the pathogen’s genome is dedicated to maintaining optimal fitness in diverse host environments.
Differential genetic requirements define virulence pathways in Mtb
To more formally investigate the distinct stresses imposed on the bacterial population across this host panel, we characterized the differentially required bacterial pathways. Upon performing each possible pairwise comparison between the in vivo selected mutant pools, we found 679 mutants whose representation varied significantly (FDR < 5%) in at least two independent comparisons (Figure 4—source data 1). We then applied weighted gene correlation network analysis (WGCNA) to divide the mutants into 20 internally-correlated modules. Further enrichment of these modules for the most representative genes (intramodular connectivity >0.6) revealed that nearly all modules contained genes that are encoded adjacently in the genome and many of these modules consisted of genes dedicated to a single virulence-associated function (Figure 5A). Module three contains two distally encoded loci both known to be necessary for ESX1-mediated protein secretion, the primary ESX1 locus (rv3868-rv3883) and the espACD operon (rv3616c-rv3614c). Similarly, other modules consisted of genes responsible for ESX5 secretion (Module 7), mycobactin synthesis (Module 4), the Mce1 and Mce4 lipid importers (Modules 5 and 16), phthiocerol dimycocerosate synthesis (PDIM, Module 8), PDIM transport (Module 16), and phosphate uptake (Module 14). The 20 genes assigned to Module six included two components of an important oxidative stress resistance complex (sseA and rv3005c) and were highly enriched for mutants predicted to be involved in this same process via genetic interaction mapping (11/20 genes were identified in, a statistically significant overlap [p < 2.8e-10 by hypergeometric test]). Thus, each module represented a distinct biological function.
Many pathway-specific modules contained genes that represented novel functional associations. For example, the gene encoding the sigma factor, sigC, was found in Module one along with a non-ribosomal peptide synthetic operon. Previous genome-wide ChIP-seq and overexpression screens support a role for SigC in regulating this operon. Similarly, rv3220c and rv1626 have been proposed to comprise an unusual two-component system that is encoded in different regions of the genome. Both of these genes are found in Module 2, along with the PPE50 and PPE51 genes that encode at least one outer membrane channel (; Figure 5A). In both cases, these associations support both regulatory and obligate functional relationships between these genes. Six of the 20 modules were not obviously enriched for genes of a known pathway, demonstrating that novel virulence pathways are important for adapting to changing host environments.
To explore the complexity of immune environments in the CC, we used the TnSeq profiles of the 679 differentially fit Mtb mutants to cluster the mouse panel into six major groups of host genotypes (Figure 5B). One mouse cluster was significantly associated with high CFU (Cluster F, Figure 5B), which contained susceptible Nos2-/-, Cybb-/-, Ifng -/-, and Rag2-/- animals. This high CFU cluster was associated with alterations in a diverse set of bacterial modules and corresponded to an increased requirement for lipid uptake (Modules 5 and 16) and ESX1, consistent with previous TnSeq studies in susceptible Nos2-/- and C3HeB/FeJ mice. In addition, we identified a significant reduction in the requirement for the oxidative stress resistance (Module 6) in the highest CFU cluster. Despite these associations between bacterial genetic requirements and susceptibility, the clustering of mouse genotypes was largely independent of overall susceptibility. Similarly, while Module one was significantly associated with high IFNγ levels, other bacterial fitness traits were not highly correlated with cytokine abundance (Figure 5—figure supplement 1). Instead, each major mouse cluster was associated with a distinct profile of Mtb genetic requirements. This observation supported the presence of qualitatively distinct disease states and complex genetic control of immunity.
Identification of genome-wide host interacting with pathogen QTL (HipQTL)
To investigate the host genetic determinants of the bacterial microenvironment, we leveraged TnSeq as a high-resolution phenotyping platform to associate Mtb mutant fitness profiles with variants in the mouse genome. When the relative abundance of each Mtb mutant phenotype was considered individually, the corresponding ‘Host Interacting with Pathogen QTL’ (HipQTL) were distributed across the mouse genome (Figure 6A). Forty-one of these traits reached an unadjusted p-value threshold of 0.05 and can be considered as robust for single hypothesis testing (Hip1-41, Table 2). These included HipQTL associated with ahpC (Hip12) and eccD1 (Hip22), that explain at least a portion of the observed variable abundance of these Mtb mutants (Figure 4E). In order to reduce complexity and increase the power of this analysis, we performed QTL mapping based on the first principal component of each of the previously defined modules of Mtb virulence pathways (Figure 5A). Three of these ‘eigentraits’ were associated with QTL at a similar position on chromosome 10 (Figure 6B), corresponding to Module 3 (TypeVII secretion, ESX1), Module 4 (mycobactin synthesis, mbt), or Module 16 (cholesterol uptake, mce4). In all three cases, a single mutant from the module was independently associated with a QTL at the same position as the module eigentrait (Table 2; Hip21, Hip22, Hip24), and all genes in the corresponding network cluster (Figure 5A) mapped to the same location (Figure 6C–E). While not all individual traits mapped with high confidence, the coincidence of these multiple QTL was statistically significant (Figure 6B).
Both the relative positions of the module-associated QTL and the associated founder haplotypes indicated that a single genetic variant controlled the abundance of ESX1 and mbt mutants (Hip42). Specifically, we found no statistical support for differentiating these QTL based on position (p = 0.93) and the same founder haplotypes were associated with extreme trait values at both loci, though they had opposite effects on the abundance of ESX1 mutants and mbt mutants (Figure 6F). We conclude that a single haplotype has a pleiotropic effect on Mtb’s environment and has opposing effects of the requirement for mycobactin synthesis and ESX1 secretion. The relationship between this variant and the mce4-associated QTL (Hip43) was less clear, as the statistical support for independent QTL was weak (ESX1 and mce4 QTL p = 0.17; mbt and mce4 QTL p = 0.08) and the effects of founder haplotypes were similar but not identical (Figure 6F). Some of this ambiguity may be related to the relatively small range in trait values for mce4, compared to either ESX1 or mbt (Figure 6G). Based on this data, we report two distinct HipQTL in this region (Hip42 and 43; Table 2).
Two TipQTL overlapped with HipQTL (Figure 7; Tip5/Hip4 on chromosome two and Tip9/Hip35 on chromosome 17), suggesting specific interactions between bacterial fitness and immunity. However, most Tip- and HipQTL were distinct, indicating that the fitness of sensitized bacterial mutants can be used to detect genetic variants that subtly influence the bacterial environment but not overtly alter disease. We chose to further investigate whether HipQTL might alter overall bacterial disease using the most significant HipQTL on chromosome 10 (Hip42). We found that the founder haplotypes associated with extreme trait values at this QTL could differentiate CC strains with significantly altered total bacterial burden, and the NOD and WSB haplotypes were associated with higher bacterial numbers (p = 0.0085 for spleen CEQ; P = 0.027 for spleen CFU; Figure 6H). Thus, not only could the HipQTL strategy identify specific interactions between host and bacterial genetic variants, but it also appears to be a sensitive approach for identifying host loci that influence the trajectory of disease.
Identifying candidate genes underlying QTL
A pipeline was designed to prioritize genetic variants based on genomic and tuberculosis disease criteria. We concentrated on three QTL: two that were highly significant and with clear allele effects (Tip5, Hip42), and the Tip8 locus which we validated by intercross. For each QTL region, we identified genes that belonged to a differentially expressed transcriptional module in mouse lungs following Mtb infection. Next, we identified genetic variants segregating between the causal CC haplotypes in the gene bodies corresponding to these transcripts, and prioritized missense or nonsense variants.
For the Tip5 QTL underlying CEQ, CFU, and IL-10 levels, we identified nine candidate genes with regulatory or splicing variants and two genes with missense variants specific to the NOD haplotype. Of these candidates, cathepsin Z (Ctsz) encodes a lysosomal cysteine proteinase and has previously been associated with TB disease risk in humans. The QTL underlying lung CFU and CXCL1 abundance (Tip8), which was driven solely by the genetically divergent CAST founder haplotype, contained over 50 genes (Table 3) and will need further refinement. The QTL associated with the abundance of ESX1 and mbt mutants (Hip42) had a complex causal haplotype pattern (AJ/B6/NZO vs. 129/CAST/PWK vs. NOD/WSB) suggesting multiple variants might be impacting common genes. Within this interval, we identified 13 genes expressed in response to Mtb infection, three of which had SNPs fully or partially consistent with at least one of the identified causal haplotype groups (Table 3). Ank3 contains several SNPs in the 3’ UTR and other non-coding exons that differentiated NOD/WSB from the other haplotypes. Similarly, Fam13c had two missense mutations following the same haplotype pattern. For the AJ/B6 haplotype state, we identified a missense mutation and several variants in the 3’ UTR of Rhobtb1, which belongs to the Rho family of the Ras superfamily of small GTPases. Overall, the evidence supports a role for Rhobtb1 in a monogenic effect at the chromosome 10 locus. This evidence includes both protein coding differences dividing AJ/B6 from the other haplotypes, a potential expression/transcript regulatory difference that segregates the NOD/WSB state from the remaining parental haplotypes, and a plausible role for this gene in controlling intracellular trafficking and the opposing requirements for ESX1 and mycobactin.
Discussion
Our broad profiling of both host and pathogen traits after Mtb infection in a large panel of CC strains, created a reproducible resource to study the diverse host-pathogen interactions that drive tuberculosis disease. The immunological analysis of the CC panel identified correlates of TB disease progression that were consistent with previous studies in both mice and human patients. We also identified outlier strains that produce distinct immunological states, suggesting that our previous reliance on genetically homogenous lab strains of mice has oversimplified our understanding of TB pathogenesis. For example, despite the strong correlation between lung bacterial burden and weight loss, CC030/GeniUnc and CC040/TauUnc mice suffered from more inflammation and wasting than would be predicted from the number of bacteria in their lungs or spleens. This phenotype reflects a failure of disease ‘tolerance’, which is proposed to be a critical determinant of protective immunity. Similarly, we identified a number of CC genotypes that produce very low, or undetectable, levels of the protective cytokine IFNγ, but still control lung bacterial replication. While a growing body of literature suggests that immune responses distinct from the canonical Th1 response can control infection, these CC strains are the first example of an animal model in which IFNγ appears to be dispensable. Despite the relatively small group sizes used in this initial phenotypic screen, the reproducibility of the CC strains facilitated the identification of these phenotypes and provides tractable models for further characterization.
The ability to separate aspects of the immune response from disease progression implied that these features are under distinct multigenic control. Our study demonstrated the feasibility of mapping the genetic variants that control the complex immune response to Mtb. The QTL identified in this study are generally distinct from CC loci that control immunity to viruses or another intracellular bacterial pathogen, Salmonella. However, Tip8 and Tip10 overlap with QTL previously defined via Mtb infection of a CC001xCC042 F2 intercross population suggesting that common variants may have been identified in both studies. While the specific genetic variants responsible for these QTL remain unknown, both coincident trait mapping and bioinformatic analysis suggest mechanistic explanations for some QTL-phenotype associations. For example, a single interval on chromosome two controls CFU levels and IL-10, and contains a variant in the Ctsz gene encoding Cathepsin Z. Ctsz is a strong candidate considering its known roles in autophagy, dendritic cell differentiation and function, its upregulation in non-human primates and human patients with Mtb, and the association of CTSZ variants with disease risk in human TB studies. Regardless of the responsible variants, these data will facilitate the generation of new congenic animal models that isolate the contribution of each QTL to phenotype.
Using TnSeq as a multidimensional phenotyping method across this population provided insight into how the diversity of host-derived microenvironments have shaped the pathogen’s genome. While Mtb is an obligate pathogen with no significant environmental niche, only a minority of the genes in its genome have been found to contribute to bacterial fitness in either laboratory media or individual inbred mouse models, leaving the pressures that maintain the remaining genomic content unclear. Our study indicated that a roughly similar number of genes are important for Mtb fitness in a given mouse strain, even immunodeficient strains that likely represent the most divergent environments. While this observation may seem counterintuitive, it is consistent with previous TnSeq studies in both mouse models and in vitro conditions, where distinct but similarly sized gene sets are necessary for growth under very different conditions. Overall, we find that approximately three times more genes contribute to bacterial growth or survival in the CC population than in the standard B6 model. While some bacterial genetic requirements could be associated with known immune pathways, most of the differential pressures on bacterial mutants could not be attributed to these simple deficiencies in known mechanisms of immune control. Instead, it appears that the CC population produces a spectrum of novel environments, and that a relatively large fraction of the pathogen’s genome is needed to adapt to changing immune pressures. Differential pressures on these adaptive virulence functions are similarly apparent in genomic analyses of Mtb clinical isolates. Signatures of selection have been detected in ESX1-related genes, phoPR, and the oxidative stress resistance gene sseA, suggesting that Mtb is exposed to similarly variable host pressures in genetically diverse human and mouse populations. While the combinatorial complexity of associating host and pathogen genetic variants in natural populations is daunting, the identification of HipQTL in the CC panel indicates that these inter-species genetic interactions can be important determinants of pathogenesis and can be dissected using this tractable model of diversity.
Mice
Male and female Collaborative Cross parental strains (A/J #0646; C57BL/6 J #0664; 129S1/SvImJ #02448; NOD/ShiLtJ #01976; NZO/HiLtJ #02105; CAST/EiJ #0928, PWK/PhJ #3,715 and WSB/EiJ #01145) and single gene immunological knockout mice were purchased from The Jackson Laboratory (Nos2-/- #2609, Cybb-/- #2365, Ifnγ-/- #2287) or Taconic (RagN12) and bred at UMASS. Male mice from 52 CC strains were purchased from the UNC Systems Genetics Core Facility (SGCF) between July 2013 and August 2014. The 52 CC strains used in this study include: CC001/Unc, CC002/Unc, CC003/Unc, CC004/TauUnc, CC005/TauUnc, CC006/TauUnc, CC007/Unc, CC008/GeniUnc, CC009/Unc, CC010/GeniUnc, CC011/Unc, CC012/GeniUnc, CC013/GeniUnc, CC015/Unc, CC016/GeniUnc, CC017/Unc, CC018/Unc, CC019/TauUnc, CC021/Unc, CC022/GeniUnc, CC023/GeniUnc, CC024/GeniUnc, CC025/GeniUnc, CC027/GeniUnc, CC028/GeniUnc, CC029/Unc, CC030/GeniUnc, CC031/GeniUnc, CC032/GeniUnc, CC033/GeniUnc, CC034/Unc, CC035/Unc, CC037/TauUnc, CC038/GeniUnc, CC039/Unc, CC040/TauUnc, CC041/TauUnc, CC042/GeniUnc, CC043/GeniUnc, CC044/Unc, CC045/GeniUnc, CC046/Unc, CC047/Unc, CC051/TauUnc, CC055/TauUnc, CC056/GeniUnc, CC057/Unc, CC059/TauUnc, CC060/Unc, CC061/GeniUnc, CC065/Unc, CC068/TauUnc. More information regarding the CC strains can be found at http://csbio.unc.edu/CCstatus/index.py?run=AvailableLines.information.
CC030 x CC029 F2 mice were generated in the FPMV lab at UNC by crossing CC030 and CC029 mice (purchased from the SGCF in 2016) to generate F1s (both CC030 dam by CC029 sires as well as CC029 dam by CC030 sires). The resulting F1s were subsequently intercrossed to generate 251 F2 mice with all possible grandparental combinations. Male and female F2 mice were shipped to UMASS for Mtb infections.
All mice were housed in a specific pathogen-free facility under standard conditions (12 hr light/dark, food and water ad libitum). Mice were infected with Mtb between 8 and 12 weeks of age. Male mice were used for initial large CC screen; male and female mice were used for F2 validation cohort.
M. tuberculosis trains
All M. tuberculosis strains (H37Rv background) were grown in Middlebrook 7H9 medium containing oleic acid-albumin-dextrose-catalase (OADC), 0.2% glycerol, and 0.05% Tween 80 to log-phase with shaking (200 rpm) at 37 °C. Hygromycin (50 µg/ml) or kanamycin (20 µg/ml) was added when necessary. The TnSeq library consisting of Himar1 transposon mutants was described previously. The ∆bioA strain was made by homologous recombination as previously described. For pooled mutant infections, deletion strains (GlpK, PstC2, EccB1, MbtA) were constructed using ORBIT, which included gene replacement by the vector pKM464 carrying unique q-Tag sequences to identify each mutant for deep sequencing. The rnaseJ mutant was also made by ORBIT and was kindly provided by Dr. Nathan Hicks and Dr Sarah Fortune. Prior to all in vivo infections, cultures were washed, resuspended in phosphate-buffered saline (PBS) containing 0.05% Tween 80, and sonicated before diluting to desired concentration (see below).
Mouse infections
For TnSeq experiments, 1 × 106 CFU of a saturated library of Himar1 transposon mutants was delivered via intravenous tail vein injection, resulting in an infectious dose (Day 1 CFU) of 105 in the spleen and 104 in the lung. For the TnSeq screen, groups of three to six mice per genotype were infected, including 52 CC strains, 8 parental strains, and single-gene knockout mice (Nos2-/-, Cybb-/-, Ifnγ-/- and RagN12). Mice were infected over three infection batches, as denoted in Figure 1—source data 1. Burden and immunological data from all surviving animals are provided in Figure 1—source data 1. At indicated time points mice were euthanized, and organs were harvested then homogenized in a FastPrep-24 (MP Biomedicals). CFU was determined by dilution plating on 7H10 agar with 20 µg/mL kanamycin. For library recovery, approximately 1 × 106 CFU per mouse was plated on 7H10 agar with 20 µg/mL kanamycin. After three weeks of growth, colonies were harvested by scraping and genomic DNA was extracted. The relative abundance of each transposon mutant was estimated as described.
Single strain validation aerosol infections were performed in a Glas-Col machine to deliver 50–150 CFU/mouse. At indicated time points, mice were euthanized, and organs were harvested then homogenized in a FastPrep-24 (MP Biomedicals). CFU was determined by dilution plating on 7H10 agar with 20 ug/mL kanamycin or 50 µg/mL hygromycin as required.
Chromosomal equivalent (CEQ) was enumerated according to previously published protocol. Cytokines and chemokines were assayed from organ homogenates using the pro-inflammatory focused 32-plex (Eve Technologies, Calgary, CA).
For pooled mutant infections, three to five mice per genotype (B6, CC051, PWK, CC042, CC005, CC018) were infected with a pool of deletion mutants at equal ratios via the intravenous route (1 × 106 CFU/mouse resulting in an infectious dose (D1 CFU) of 1 × 105 in the spleen). At indicated time points, approximately 10,000 CFU from the spleen homogenate of each mouse was plated on 7H10 agar. Genomic DNA was extracted for sequencing as described previously. Sequencing libraries spanning the variable region of each q-Tag were generated using PCR primers binding to regions common among all q-Tags, similar to previously described protocols. In each PCR, a unique molecular counter was incorporated into the sequence to allow for the accurate counting of input templates and account for PCR jackpotting. The libraries were sequenced to 1000-fold coverage on an Illumina NextSeq platform using a 150-cycle Mid-Output kit with single-end reads. Total abundance of each mutant in the library was determined by counting the number of reads for each q-Tag with a unique molecular counter. Relative abundance of each mutant in the pool was then calculated by dividing the total abundance of a mutant by the total abundance of reads for wild-type H37Rv. The relative abundance was normalized to relative abundance at initial infection (Day 0) and log2 transformed. Fitness was calculated as previously described. Burden and normalized counts from all Mtb mutants in each mouse are provided in Figure 4—source data 2.
For CC030 x CC029 F2 infections, 251 F2 mice (including equivalent numbers of male and female mice) were infected via IV route with an infectious dose of 105 CFU of TnSeq library (as described above), to replicate the original CC infection experimental conditions. Mice were sacrificed at 1 month post-infection and bacterial burden was quantified by plating for CFU (as described above).
TnSeq analysis
TnSeq libraries were prepared and counts of each transposon mutant were estimated as described. NCBI Reference Sequence NC_018143.1 was used for H37Rv genome and annotations. A total of 123 libraries were sequenced, capturing 60 distinct mouse genotypes. In the majority of cases, two replicate mouse libraries were used per genotype. Only a single TnSeq library was obtained for CC010, CC031, CC037, CC059, CC016, and PWK/PhJ. Insertion mutant counts across all libraries were normalized by beta-geometric correction, binned by gene, and replicate values for each mouse genotype averaged. Mean values for each gene were divided by the grand mean then log2 transformed and quantile normalized. The resulting phenotype values were used for both WGCNA and QTL mapping.
To eliminate genes having no meaningful variation across the mouse panel, statistical tests of log2 fold change (LFC) in counts between all possible pairs of mouse genotypes were performed by resampling. 679 ‘significantly varying genes’ were identified whose representation varied significantly (FDR < 5%) in at least two independent comparisons. For relative mutant abundance estimates, LF C in counts between in vitro-grown H37Rv (six replicate libraries) vs libraries from each mouse genotype were determined by resampling as above. LFC, Q-values and modules for TnSeq data across the mouse strains is available in Figure 4—source data 1.
WGCNA analysis
Weighted gene correlation network analysis (WGCNA) was applied to categorize the 679 significantly varying genes into 20 internally-correlated modules. Modules were filtered (intramodular connectivity >0.6) to obtain the most representative genes. First principal component scores of module eigengenes were used as phenotype values for QTL mapping after first winsorizing (q = 0.05) using the R package broman (https://cran.r-project.org/web/packages/broman/index.html).
In order to perform association analysis between modules of genes and clusters of mice (Figure 5B), the mice were clustered based on the matrix of TnSeq LFCs for significantly varying genes using hclust in R (with the ‘Ward.D2’ distance metric). Then, for each module of genes, the LFCs in each cluster of mice were pooled and compared to all the other mice using a t-test, identifying modules with a mean LFC in a specific mouse cluster that is significantly higher or lower than the average across all the other mice. The resulting p-values over all combinations of gene modules and mouse clusters were adjusted using Benjamini-Hochberg for an overall FDR < 0.05.
Disease-related trait analysis and heritability estimation
For the trait heatmap, trait values were clustered (hclust in R package heatmaply; traits scaled as per default function) and dendrogram nodes colored by 3 k-means. Correlation between disease-related TB traits for both IV and aerosol validation experiments was determined by Pearson’s correlation and visualized using corrplot (ordered by hclust) (Figure 1—figure supplements 1 and 2). Heritability (h2) of the immunological and TB disease-related traits was calculated by estimating the percent of variation attributed to between strain differences relative to within strain noise as previously described (Appendix1). This is explicitly: SS(strain)/SS(total) in an ANOVA table (where SS(total) is SS(strain)+ SS(error)) (SS; sum of squares). p-Values were calculated by ANOVA and multiple-test corrected using the Benjamini-Hochberg method. Throughout the text, correlations are cited using the following standardized nomenclature: 0–0.19 = very weak, 0.2–0.39 = weak, 0.40–0.59 = moderate, 0.6–0.79 = strong, 0.8–1.0 = very strong correlation.
Genotyping and QTL mapping
A subset of the inbred CC mice used in the analysis were genotyped on the GigaMUGA array available from Neogen Inc The inbred parents, F1s and F2 mice from the CC030xCC029 cross were genotyped on the MiniMUGA array at Neogen Inc, For CC030 x CC029 F2 QTL analysis, markers were filtered to 2499 markers that differentiated between CC029 and CC030 haplotypes (Figure 3—source data 1). For QTL mapping in the F2 panel, genotype (Figure 3—source data 1) and lung burden data (Figure 3—source data 2) from 251 Mtb-infected F2 individuals was imported into R (version 3.6.1) and formatted for R/qtl2 (version 0.20). QTL mapping incorporated kinship as a covariate using the LOCO (Leave One Chromosome Out) method. Further, sex and infection batch were also considered as covariates for mapping. LOD scores were calculated within R/qtl2 to assess genotypic associations with lung burden at each marker. QTL significance thresholds were established by 10,000 permutations.
For QTL mapping in the CC panel, the Most Recent Common Ancestor 36-state haplotypes were downloaded from the UNC Systems Genetics Core Facility and simplified to 8-state haplotype probabilities (for the 8 CC founder strains), which is appropriate for additive genetic mapping. We generated 36-state haplotype probabilities from the individual CC mice genotyped on GigaMUGA and combined these data with the MRCA data to obtain a common genome cache.
For CC QTL analysis, genotype and phenotype data were imported into R (version 3.6.1) and reformatted for R/qtl2 (version 0.20). Individual TnSeq and clinical trait phenotype values were winsorized (q = 0.006) as above. GigaMUGA annotations were downloaded from the Jackson Laboratory, and markers were thinned to a spacing of 0.1 cM using the reduce_markers function of R/qtl2. The final genetic map contained 10,067 markers. QTL mapping was carried out using a linear mixed model with LOCO (leave one chromosome out) kinship. For clinical trait scans, batch (denoted by ‘block’ in Figure 1—source data 1) was included as an additive covariate. Significance thresholds for QTL were estimated using 10,000 permutations (scan1_perm function). For each trait, the maximum LOD scores from the permutation scans were used to fit generalized extreme value distributions, from which genome-wide permutation p-values were calculated. LOD profiles and effect plots were generated using the plotting functions of the R/qtl2 package. Multiple QTL at similar genetic locations were assessed for independence using qtl2pleio with 400 bootstrap samples. The quantile-based permutation thresholding method of was used to assess the statistical significance of co-mapping traits. The NL-method, which determines the LOD thresholds controlling genome-wide error rate for a given p-value and ‘hotspot’ size, was employed.
Candidate gene prioritization
To identify potential candidate genes, we focused on three QTL that were either statistically significant (Tip5, Hip42) or were validated by intercross (Tip8). For each QTL interval (determined by Bayesian interval in qtl2), we identified mouse genes that were in differentially expressed modules between infected lungs of resistant and susceptible mouse strains. Of these genes, we next used the Sanger sequence data to filter on genetic variants segregating between CC founder haplotypes. Where there were clear causal haplotypes, we further filtered to genes with missense or nonsense variants.
References 100
- 1.
Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, Chaturvedi N, Srinivasan S, Johnson DH, Bishai WR. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. The Lancet. Infectious Diseases. 2018;18:e64-e75.
Not in our library10.1016/s1473-3099(17)30623-0
- 2.
Adams LA, Möller M, Nebel A, Schreiber S, van der Merwe L, van Helden PD, Hoal EG. Polymorphisms in MC3R promoter and CTSZ 3’UTR are associated with tuberculosis susceptibility. European Journal of Human Genetics. 2011;19:676-681.
Not in our library10.1038/ejhg.2011.1
- 3.
Ahmed M, Thirunavukkarasu S, Rosa BA, Thomas KA, Das S, Rangel-Moreno J, Lu L, Mehra S, Mbandi SK, Thackray LB, Diamond MS, Murphy KM, Means T, Martin J, Kaushal D, Scriba TJ, Mitreva M, Khader SA. Immune correlates of tuberculosis disease and risk translate across species. Science Translational Medicine. 2020;12:eaay0233.
Not in our library10.1126/scitranslmed.aay0233
- 4.
Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Döffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (New York, N.Y.). 1998;280:1432-1435.
Not in our library10.1126/science.280.5368.1432
- 5.
Amaral EP, Riteau N, Moayeri M, Maier N, Mayer-Barber KD, Pereira RM, Lage SL, Kubler A, Bishai WR, D’Império-Lima MR, Sher A, Andrade BB. Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages. Frontiers in Immunology. 2018;9:1427.
Not in our library10.3389/fimmu.2018.01427
- 6.
Ansari MA, Pedergnana V, L C Ip C, Magri A, Von Delft A, Bonsall D, Chaturvedi N, Bartha I, Smith D, Nicholson G, McVean G, Trebes A, Piazza P, Fellay J, Cooke G, Foster GR, Hudson E, McLauchlan J, Simmonds P, Bowden R, Klenerman P, Barnes E, Spencer CCA, STOP-HCV Consortium. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nature Genetics. 2017;49:666-673.
Not in our library10.1038/ng.3835
- 7.
Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB, Gralinski LE, Bell TA, Didion JD, Hua K, Nehrenberg DL, Powell CL, Steigerwalt J, Xie Y, Kelada SNP, Collins FS, Yang IV, Schwartz DA, Branstetter LA, Chesler EJ, Miller DR, Spence J, Liu EY, McMillan L, Sarkar A, Wang J, Wang W, Zhang Q, Broman KW, Korstanje R, Durrant C, Mott R, Iraqi FA, Pomp D, Threadgill D, de Villena FP-M, Churchill GA. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Research. 2011;21:1213-1222.
Not in our library10.1101/gr.111310.110
- 8.
Ayres JS, Schneider DS. Tolerance of infections. Annual Review of Immunology. 2012;30:271-294.
Not in our library10.1146/annurev-immunol-020711-075030
- 9.
Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition. The Journal of Immunology. 2011;186:1598-1607.
Not in our library10.4049/jimmunol.1003304
- 10.
- 11.
Bellerose MM, Proulx MK, Smith CM, Baker RE, Ioerger TR, Sassetti CM, Marshall CW. Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis. MSystems. 2020;5:mSystems.00396-20.
Not in our library10.1128/msystems.00396-20
- 12.
Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, Engstrand L, Enroth H, Burette A, Megraud F, Varon C, Atherton JC, Smith S, Wilkinson TS, Hitchings MD, Falush D, Sheppard SK. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk. BMC Biology. 2018;16:84.
Not in our library10.1186/s12915-018-0550-3
- 13.
Blumenthal A, Trujillo C, Ehrt S, Schnappinger D. Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLOS ONE. 2010;5:e15667.
Not in our library10.1371/journal.pone.0015667
- 14.
Boehm FJ, Chesler EJ, Yandell BS, Broman KW. Testing Pleiotropy vs. Separate QTL in Multiparental Populations. G3: Genes, Genomes, Genetics. 2019;9:2317-2324.
Not in our library10.1534/g3.119.400098
- 15.
Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong X-F, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova J-L. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (New York, N.Y.). 2012;337:1684-1688.
Not in our library10.1126/science.1224026
- 16.
- 17.
Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Seminars in Immunology. 2014;26:454-470.
Not in our library10.1016/j.smim.2014.09.008
- 18.
Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. Journal of Immunology (Baltimore, Md. 1999;162:5407-5416.
Not in our library
- 19.
- 20.
Chen L, Xie QW, Nathan C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Molecular Cell. 1998;1:795-805.
Not in our library10.1016/s1097-2765(00)80079-9
- 21.
Churchill G.A., Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963-971.
Not in our library10.1093/genetics/138.3.963
- 22.
Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, Bleich A, Bogue M, Broman KW, Buck KJ, Buckler E, Burmeister M, Chesler EJ, Cheverud JM, Clapcote S, Cook MN, Cox RD, Crabbe JC, Crusio WE, Darvasi A, Deschepper CF, Doerge RW, Farber CR, Forejt J, Gaile D, Garlow SJ, Geiger H, Gershenfeld H, Gordon T, Gu J, Gu W, de Haan G, Hayes NL, Heller C, Himmelbauer H, Hitzemann R, Hunter K, Hsu H-C, Iraqi FA, Ivandic B, Jacob HJ, Jansen RC, Jepsen KJ, Johnson DK, Johnson TE, Kempermann G, Kendziorski C, Kotb M, Kooy RF, Llamas B, Lammert F, Lassalle J-M, Lowenstein PR, Lu L, Lusis A, Manly KF, Marcucio R, Matthews D, Medrano JF, Miller DR, Mittleman G, Mock BA, Mogil JS, Montagutelli X, Morahan G, Morris DG, Mott R, Nadeau JH, Nagase H, Nowakowski RS, O’Hara BF, Osadchuk AV, Page GP, Paigen B, Paigen K, Palmer AA, Pan H-J, Peltonen-Palotie L, Peirce J, Pomp D, Pravenec M, Prows DR, Qi Z, Reeves RH, Roder J, Rosen GD, Schadt EE, Schalkwyk LC, Seltzer Z, Shimomura K, Shou S, Sillanpää MJ, Siracusa LD, Snoeck H-W, Spearow JL, Svenson K, Tarantino LM, Threadgill D, Toth LA, Valdar W, de Villena FP-M, Warden C, Whatley S, Williams RW, Wiltshire T, Yi N, Zhang D, Zhang M, Zou F, Complex Trait Consortium. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nature Genetics. 2004;36:1133-1137.
Not in our library10.1038/ng1104-1133
- 23.
Churchill GA, Gatti DM, Munger SC, Svenson KL. The Diversity Outbred mouse population. Mammalian Genome. 2012;23:713-718.
Not in our library10.1007/s00335-012-9414-2
- 24.
Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. The American Review of Respiratory Disease. 1978;117:621-624.
Not in our library10.1164/arrd.1978.117.4.621
- 25.
Cooke GS, Campbell SJ, Bennett S, Lienhardt C, McAdam KPWJ, Sirugo G, Sow O, Gustafson P, Mwangulu F, van Helden P, Fine P, Hoal EG, Hill AVS. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2008;178:203-207.
Not in our library10.1164/rccm.200710-1554oc
- 26.
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of Experimental Medicine. 1993;178:2243-2247.
Not in our library10.1084/jem.178.6.2243
- 27.
Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. The Journal of Experimental Medicine. 1997;186:39-45.
Not in our library10.1084/jem.186.1.39
- 28.
de Keijzer J, de Haas PE, van Veelen PA, van Soolingen D. Disclosure of selective advantages in the “modern” sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics. Molecular & Cellular Proteomics: MCP. 2014;13:2632-2645.
Not in our library10.1074/mcp.m114.038380
- 29.
- 30.
Dick T, Manjunatha U, Kappes B, Gengenbacher M. Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis. Molecular Microbiology. 2010;78:980-988.
Not in our library10.1111/j.1365-2958.2010.07381.x
- 31.
- 32.
Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku C-L, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, Feinberg J, Durandy A, Senechal B, Chapgier A, Vogt G, de Beaucoudrey L, Fieschi C, Picard C, Garfa M, Chemli J, Bejaoui M, Tsolia MN, Kutukculer N, Plebani A, Notarangelo L, Bodemer C, Geissmann F, Israël A, Véron M, Knackstedt M, Barbouche R, Abel L, Magdorf K, Gendrel D, Agou F, Holland SM, Casanova J-L. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. The Journal of Experimental Medicine. 2006;203:1745-1759.
Not in our library10.1084/jem.20060085
- 33.
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. The Journal of Experimental Medicine. 1993;178:2249-2254.
Not in our library10.1084/jem.178.6.2249
- 34.
Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM. Variable host-pathogen compatibility in Mycobacterium tuberculosis. PNAS. 2006;103:2869-2873.
Not in our library10.1073/pnas.0511240103
- 35.
Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infection and Immunity. 2004;72:1733-1745.
Not in our library10.1128/iai.72.3.1733-1745.2004
- 36.
Goitre L, Trapani E, Trabalzini L, Retta SF. The Ras superfamily of small GTPases: the unlocked secrets. Methods in Molecular Biology (Clifton, N.J.). 2014;1120:1-18.
Not in our library10.1007/978-1-62703-791-4_1
- 37.
Gonzalo-Asensio J, Malaga W, Pawlik A, Astarie-Dequeker C, Passemar C, Moreau F, Laval F, Daffé M, Martin C, Brosch R, Guilhot C. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. PNAS. 2014;111:11491-11496.
Not in our library10.1073/pnas.1406693111
- 38.
Gopal R., Lin Y, Obermajer N, Slight S, Nuthalapati N, Ahmed M, Kalinski P, Khader SA. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. European Journal of Immunology. 2012;42:364-373.
Not in our library10.1002/eji.201141569
- 39.
Gopal R, Monin L, Torres D, Slight S, Mehra S, McKenna KC, Fallert Junecko BA, Reinhart TA, Kolls J, Báez-Saldaña R, Cruz-Lagunas A, Rodríguez-Reyna TS, Kumar NP, Tessier P, Roth J, Selman M, Becerril-Villanueva E, Baquera-Heredia J, Cumming B, Kasprowicz VO, Steyn AJC, Babu S, Kaushal D, Zúñiga J, Vogl T, Rangel-Moreno J, Khader SA. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2013;188:1137-1146.
Not in our library10.1164/rccm.201304-0803oc
- 40.
Gralinski LE, Menachery VD, Morgan AP, Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC, Schäfer A, Pardo-Manuel de Villena F, Ferris MT, Baric RS. Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice. G3: Genes, Genomes, Genetics. 2017;7:1653-1663.
Not in our library10.1534/g3.117.041434
Cited by papers we hold 2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.